Search research articles
Contact Us
Filters
Showing results (1-10 of 238) with videos related to
Page
of 24
Sort By:
Current Diabetes Reports
|
August 10, 2017
Tolerogenic Nanoparticles to Treat Islet Autoimmunity
Tobias Neef, Stephen D Miller
Frontiers in Immunology
|
October 30, 2020
Potential for Targeting Myeloid Cells in Controlling CNS Inflammation
Igal Ifergan, Stephen D Miller
Current Opinion in Endocrinology, Diabetes, and Obesity
|
June 8, 2021
Novel delivery mechanisms for antigen-specific immunotherapy
Tobias Neef, Stephen D Miller
Plos One
|
April 16, 2011
CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease
D'Anne S Duncan, Stephen D Miller
Cellular Immunology
|
April 9, 2014
Molecular control of monocyte development
Rachael L Terry, Stephen D Miller
Neurological Research
|
October 4, 2005
Role of immunologic cross-reactivity in neurological diseases
Anne M Ercolini, Stephen D Miller
Drugs of Today (Barcelona, Spain : 1998)
|
October 29, 2004
Towards cannabis and cannabinoid treatment of multiple sclerosis
J Ludovic Croxford, Stephen D Miller
Journal of Autoimmunity
|
February 10, 2007
Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities
Cassandra E Smith, Stephen D Miller
Journal of Immunology (Baltimore, Md. : 1950)
|
February 6, 2007
Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis
Danielle M Turley, Stephen D Miller
Results and Problems in Cell Differentiation
|
January 9, 2009
Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis
Danielle M Turley, Stephen D Miller
Page
of 24
Search research articles
Search
Showing results (1-10 of 238) with videos related to
Sort By:
Page
of 24
Current Diabetes Reports
|
August 10, 2017
Tolerogenic Nanoparticles to Treat Islet Autoimmunity
Tobias Neef, Stephen D Miller
Frontiers in Immunology
|
October 30, 2020
Potential for Targeting Myeloid Cells in Controlling CNS Inflammation
Igal Ifergan, Stephen D Miller
Current Opinion in Endocrinology, Diabetes, and Obesity
|
June 8, 2021
Novel delivery mechanisms for antigen-specific immunotherapy
Tobias Neef, Stephen D Miller
Plos One
|
April 16, 2011
CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease
D'Anne S Duncan, Stephen D Miller
Cellular Immunology
|
April 9, 2014
Molecular control of monocyte development
Rachael L Terry, Stephen D Miller
Neurological Research
|
October 4, 2005
Role of immunologic cross-reactivity in neurological diseases
Anne M Ercolini, Stephen D Miller
Drugs of Today (Barcelona, Spain : 1998)
|
October 29, 2004
Towards cannabis and cannabinoid treatment of multiple sclerosis
J Ludovic Croxford, Stephen D Miller
Journal of Autoimmunity
|
February 10, 2007
Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities
Cassandra E Smith, Stephen D Miller
Journal of Immunology (Baltimore, Md. : 1950)
|
February 6, 2007
Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis
Danielle M Turley, Stephen D Miller
Results and Problems in Cell Differentiation
|
January 9, 2009
Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis
Danielle M Turley, Stephen D Miller
Page
of 24